Indaptus Therapeutics | S-1:证券上市注册声明
Indaptus Therapeutics | D:发行公告
Indaptus Therapeutics | 4:持股变动声明-高管 Meckler Jeffrey A
Indaptus Therapeutics | SC 13D/A:超过5%持股股东披露文件(修正)-Jeffrey A. Meckler(6.9%)
Indaptus Therapeutics | 8-K:重大事件
Indaptus Therapeutics | 424B5:募资说明书
Indaptus Therapeutics | 10-Q:2024财年三季报
Indaptus Therapeutics | 8-K:Indaptus Therapeutics公布2024年第三季度财务业绩并提供公司最新情况
Indaptus Therapeutics | 8-K:重大事件
Indaptus Therapeutics | SC 13D:超过5%持股股东披露文件-Jeffrey A. Meckler(7.3%)
Indaptus Therapeutics | 4:持股变动声明-高管 Newman Michael James
Indaptus Therapeutics | 4:持股变动声明-高管 Linscott Walt Addison
Indaptus Therapeutics | 4:持股变动声明-高管 Meckler Jeffrey A
Indaptus Therapeutics | 4:持股变动声明-高管 Waltzman Roger J.
Indaptus Therapeutics | 4:持股变动声明-高管 Sassi Nir
Indaptus Therapeutics | D/A:发行公告(修正)
Indaptus Therapeutics | EFFECT:其他
Indaptus Therapeutics | CORRESP:信函
Indaptus Therapeutics | UPLOAD:其他
Indaptus Therapeutics | S-1:证券上市注册声明
暂无数据